lncRNAs as Hallmarks for Individualized Treatment of Gastric Cancer

被引:3
作者
Wu, Jing [1 ,2 ]
Xu, Shan [1 ,2 ]
Li, Wei [1 ,2 ]
Lu, Yuru [1 ,3 ]
Zhou, Yu [4 ,5 ]
Xie, Ming [1 ,6 ]
Luo, Yichen [1 ,2 ]
Cao, Yijing [1 ,7 ]
He, Yan [1 ,8 ]
Zeng, Tiebing [2 ,9 ,10 ]
Ling, Hui [1 ,2 ]
机构
[1] Univ South China, Hengyang Med Coll, Canc Res Inst, Coll Hunan Prov,Key Lab Tumor Cellular & Mol Path, Hengyang 421001, Hunan, Peoples R China
[2] Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Hengyang 421001, Hunan, Peoples R China
[3] Univ South China, Hengyang Med Coll, Class 15, Clin Med 2018, Hengyang 421001, Hunan, Peoples R China
[4] Shaoyang Univ, Shaoyang 422000, Hunan, Peoples R China
[5] Shaoyang Univ, Affiliated Hosp 1, Shaoyang 422000, Hunan, Peoples R China
[6] Univ South China, Hengyang Med Coll, Clin Med Excellence Class 2018, Class 2, Hengyang 421001, Hunan, Peoples R China
[7] Univ South China, Affiliated Hosp 2, Dept Pathol, Hengyang 421001, Hunan, Peoples R China
[8] Longgang Cent Hosp, Dept Pathol, Shenzhen 518000, Guangdong, Peoples R China
[9] Univ South China, Inst Pathogen Biol, Hengyang 421001, Hunan, Peoples R China
[10] Univ South China, Key Lab Special Pathogen Prevent & Control Hunan, Hengyang 421001, Hunan, Peoples R China
关键词
Gastric cancer; lncRNAs; hallmarks; drug resistance; target; EMT; LONG NONCODING RNA; EPITHELIAL-MESENCHYMAL TRANSITION; PROMOTES CELL-PROLIFERATION; CISPLATIN RESISTANCE; MULTIDRUG-RESISTANCE; CHEMOTHERAPY RESISTANCE; MODULAR SCAFFOLD; FEEDBACK LOOP; HUMAN GENOME; EXPRESSION;
D O I
10.2174/1871520621666210706113102
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gastric cancer is a global cancer with a high mortality rate. A growing number of studies have found the abnormal expression of lncRNA (long noncoding RNA) in many tumors, which plays a role in promoting or inhibiting cancer. Similarly, lncRNA abnormal expression plays an essential biological function in gastric cancer. This article focuses on lncRNA involvement in the development of gastric cancer in terms of cell cycle disorder, apoptosis inhibition, metabolic remodeling, promotion of tumor inflammation, immune escape, induction of angiogenesis, and Epithelial Mesenchymal Transition (EMT). The involvement of lncRNA in the development of gastric cancer is related to drug resistance, such as cisplatin and multi-drug resistance. It can also be used as a potential marker for the diagnosis and prognosis of gastric cancer and a target for the treatment. With an in-depth understanding of the mechanism of lncRNA in gastric cancer, new ideas for personalized treatment of gastric cancer are expected.
引用
收藏
页码:1440 / 1457
页数:18
相关论文
共 160 条
[1]   Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis [J].
Adams, D. ;
Gonzalez-Duarte, A. ;
O'Riordan, W. D. ;
Yang, C. -C. ;
Ueda, M. ;
Kristen, A. V. ;
Tournev, I. ;
Schmidt, H. H. ;
Coelho, T. ;
Berk, J. L. ;
Lin, K. -P. ;
Vita, G. ;
Attarian, S. ;
Plante-Bordeneuve, V. ;
Mezei, M. M. ;
Campistol, J. M. ;
Buades, J. ;
Brannagan, T. H., III ;
Kim, B. J. ;
Oh, J. ;
Parman, Y. ;
Sekijima, Y. ;
Hawkins, P. N. ;
Solomon, S. D. ;
Polydefkis, M. ;
Dyck, P. J. ;
Gandhi, P. J. ;
Goyal, S. ;
Chen, J. ;
Strahs, A. L. ;
Nochur, S. V. ;
Sweetser, M. T. ;
Garg, P. P. ;
Vaishnaw, A. K. ;
Gollob, J. A. ;
Suhr, O. B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (01) :11-21
[2]   Context-dependent EMT programs in cancer metastasis [J].
Aiello, Nicole M. ;
Kang, Yibin .
JOURNAL OF EXPERIMENTAL MEDICINE, 2019, 216 (05) :1016-1026
[3]   Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity [J].
Amodio, Nicola ;
Stamato, Maria Angelica ;
Juli, Giada ;
Morelli, Eugenio ;
Fulciniti, Mariateresa ;
Manzoni, Martina ;
Taiana, Elisa ;
Agnelli, Luca ;
Cantafio, Maria Eugenia Gallo ;
Romeo, Enrica ;
Raimondi, Lavinia ;
Caracciolo, Daniele ;
Zuccala, Valeria ;
Rossi, Marco ;
Neri, Antonino ;
Munshi, Nikhil C. ;
Tagliaferri, Pierosandro ;
Tassone, Pierfrancesco .
LEUKEMIA, 2018, 32 (09) :1948-1957
[4]   Pharmacology of Antisense Drugs [J].
Bennett, C. Frank ;
Baker, Brenda F. ;
Nguyen Pham ;
Swayze, Eric ;
Geary, Richard S. .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 57, 2017, 57 :81-105
[5]   Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses [J].
Cabili, Moran N. ;
Trapnell, Cole ;
Goff, Loyal ;
Koziol, Magdalena ;
Tazon-Vega, Barbara ;
Regev, Aviv ;
Rinn, John L. .
GENES & DEVELOPMENT, 2011, 25 (18) :1915-1927
[6]   Serum Exosomal Long Noncoding RNA pcsk2-2:1 As A Potential Novel Diagnostic Biomarker For Gastric Cancer [J].
Cai, Chenchen ;
Zhang, Haoliang ;
Zhu, Yingxing ;
Zheng, Peiming ;
Xu, Yinhai ;
Sun, Jingfang ;
Zhang, Miaomiao ;
Lan, Ting ;
Gu, Bing ;
Li, Shibao ;
Ma, Ping .
ONCOTARGETS AND THERAPY, 2019, 12 :10035-10041
[7]   The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression [J].
Cano, A ;
Pérez-Moreno, MA ;
Rodrigo, I ;
Locascio, A ;
Blanco, MJ ;
del Barrio, MG ;
Portillo, F ;
Nieto, MA .
NATURE CELL BIOLOGY, 2000, 2 (02) :76-83
[8]   RETRACTED: Long Noncoding RNA UCA1 Regulates PRL-3 Expression by Sponging MicroRNA-495 to Promote the Progression of Gastric Cancer (Retracted Article) [J].
Cao, Yi ;
Xiong, Jian-Bo ;
Zhang, Guo-Yang ;
Liu, Yi ;
Jie, Zhi-Gang ;
Li, Zheng-Rong .
MOLECULAR THERAPY NUCLEIC ACIDS, 2020, 19 :853-864
[9]   A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA [J].
Cesana, Marcella ;
Cacchiarelli, Davide ;
Legnini, Ivano ;
Santini, Tiziana ;
Sthandier, Olga ;
Chinappi, Mauro ;
Tramontano, Anna ;
Bozzoni, Irene .
CELL, 2011, 147 (02) :358-369
[10]   STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy [J].
Chen, Jin-Fei ;
Wu, Peng ;
Xia, Rui ;
Yang, Jian ;
Huo, Xin-Ying ;
Gu, Dong-Ying ;
Tang, Cui-Ju ;
De, Wei ;
Yang, Fen .
MOLECULAR CANCER, 2018, 17